Upstream's breeding technologies, which protect plants from yield-threatening diseases, have already delivered strong results ...

Zhengye Biotechnology (ZYBT) priced its initial public offering of 1.5M shares at a public offering price of $4.00 per share.

The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...

BOSTON, MASSACHUSETTS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, ...

Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, tissue-targeted medicines, today ...

Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show gains.

Vitalik Buterin has sold several meme coins to fund his biotech charity, Kanro, which supports biotechnology research.

Shares of Puma Biotechnology, Inc. PBYI have rallied 24% in the past three months against the industry’s decline of 9.7%. The ...

UNITY Biotechnology (UBX) strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical ...

Swiss medical-aesthetics company Teoxane, which already owns about 6.2% of Revance, on Monday said it has proposed acquiring the rest of the Nashville, Tenn., biotechnology company for $3.60 a share ...

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...